Next Article in Journal
Understanding the Impact of Approved but Unfunded Vaccine Status on Parental Acceptance of an Adjuvanted Seasonal Influenza Vaccine for Infants: Results from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)–III
Next Article in Special Issue
Twitter-Based Sentiment Analysis and Topic Modeling of Social Media Posts Using Natural Language Processing, to Understand People’s Perspectives Regarding COVID-19 Booster Vaccine Shots in India: Crucial to Expanding Vaccination Coverage
Previous Article in Journal
Influenza Vaccination among Multiple Sclerosis Patients during the COVID-19 Pandemic
Previous Article in Special Issue
Vaccine Acceptance and Hesitancy among Hospitalized COVID-19 Patients in Punjab, Pakistan
 
 

Order Article Reprints

Journal: Vaccines, 2022
Volume: 10
Number: 1767

Article: Vaccine Adverse Events Following COVID-19 Vaccination with Inactivated Vaccines in Zimbabwe
Authors: by Azure Tariro Makadzange, Patricia Gundidza, Charles Lau, Norest Beta, Nellie Myburgh, Nyasha Elose, Wilmot James, Lawrence Stanberry and Chiratidzo Ndhlovu
Link: https://www.mdpi.com/2076-393X/10/10/1767

MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.

If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.

Reprint Options

If you need more than 400 copies, please contact us by e-mail (publisher@mdpi.com) and we will prepare an individual offer for you.

Order Cost and Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop